| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.3 | 0.09 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.25 | 0.09 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.19 | 0.5 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0002 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.001 |